ω-6 Polyunsaturated fatty acid-stimulated cellular internalization of phosphorothioate oligodeoxynucleotides. Evidence for protein kinase C-ζ dependency

Biochemical Pharmacology

Volumn 58, Issue 3, 1999, Pages 411-423

  Khaled, Zahangir ^a   Ho, Yuan Yuan ^a   Benimetskaya, Lyuba ^a   Deckelbaum, Richard J ^a   Stein, C A ^a  

^a Columbia Univ Coll Phys Surgs ^*  (United States)

Author keywords

Internalization; Phosphorothioate oligodeoxynucleotide; PKC ; Polyunsaturated fatty acid

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; ALBUMIN; ARACHIDONIC ACID; CATION; DIOLEOYLPHOSPHATIDYLETHANOLAMINE; ENZYME INHIBITOR; FLUORESCEIN; ISOENZYME; LINOLEIC ACID; LIPID; MIDOSTAURIN; MUTANT PROTEIN; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; OMEGA 6 FATTY ACID; PHOSPHATIDYLINOSITOL 3 KINASE; POLYUNSATURATED FATTY ACID; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C INHIBITOR; WORTMANNIN;

ADSORPTION; ANIMAL CELL; ARTICLE; CELL STRAIN 3T3; CELL STRAIN HL 60; CELL STRAIN K 562; CELL SURFACE; CONTROLLED STUDY; DRUG BINDING; DRUG SYNTHESIS; ENDOCYTOSIS; HUMAN; HUMAN CELL; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CERAMIDES; ENDOCYTOSIS; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; HL-60 CELLS; HUMANS; JURKAT CELLS; K562 CELLS; MUTATION; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN KINASE C; SERUM ALBUMIN; TETRADECANOYLPHORBOL ACETATE; THIONUCLEOTIDES;

EID: 0032973996     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00126-4     Document Type: Article

References (43)

1. Stein C.A., Cheng Y.C. Antisense oligonucleotides Is the bullet really magical? Science. 261:1993;1004-1012.
2. Vaerman J.L., Moureau P., Deldime F., Lewalle P., Lammineur C., Morschhauser F., Martiat P. Antisense oligodeoxyribonucleotides suppress hematologic cell growth through stepwise release of deoxyribonucleotides. Blood. 90:1997;331-339.
3. Dean N.M., McKay R. Inhibition of protein kinase C-α expression in mice after systemic administration of phosphorothioate antisense oligodeoxynucleotides. Proc Natl Acad Sci USA. 91:1994;11762-11766.
4. Ratajczak M.Z., Kant J.A., Luger S.M., Hijiya N., Zhang J., Zon G., Gewirtz A.M. In vivo treatment of human leukemia in a scid mouse model with c-myb antisense oligodeoxynucleotides. Proc Natl Acad Sci USA. 89:1992;11823-11827.
5. Guvakova M.A., Yakubov L.A., Vlodavsky I., Tonkinson J.L., Stein C.A. Phosphorothioate oligodeoxynucleotides bind to basic fibroblast growth factor, inhibit its binding to cell surface receptors, and remove it from low affinity binding sites on extracellular matrix. J Biol Chem. 270:1995;2620-2627.
6. Yakubov L.A., Deeva E.A., Zarytova V.F., Ivanova E.M., Ryte A.S., Yurchenko L.V., Vlassov V.V. Mechanism of oligonucleotide uptake by cells Involvement of specific receptors? Proc Natl Acad Sci USA. 86:1989;6454-6458.
7. Benimetskaya L., Loike J.D., Khaled Z., Silverstein S.C., Cao L., Cai T.Q., Stein C.A. Mac-1 (CD11b/CD18) is a cell surface oligodeoxynucleotide binding protein. Nat Med. 3:1997;414-420.
8. Yao G.Q., Corrias S., Cheng Y.C. Identification of two oligodeoxyribonucleotide binding proteins on plasma membranes of human cell lines. Biochem Pharmacol. 51:1996;431-436.
9. Beltinger C., Saragovi H.V., Smith R.M., LeSauteur L., Shah N., DeDionisio L., Christensen L., Raible A., Jarett L., Gewirtz A.M. Binding, uptake, and intracellular trafficking of phosphorothioate-modified oligodeoxynucleotides. J Clin Invest. 95:1995;1814-1823.
10. Bennett C.F., Chiang M.V., Chan H., Shoemaker J., Mirabelli C. Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides. Mol Pharmacol. 41:1992;1023-1033.
11. Kukowska-Latallo J.F., Bielinska A.J., Johnson J., Spindler R., Tomalia D.A., Baker J.R. Jr. Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. Proc Natl Acad Sci USA. 93:1996;4897-4902.
12. Stein C.A., Tonkinson J.L., Zhang L.M., Yakubov L., Gervasoni J., Taub R., Rotenberg S.A. Dynamics of the internalization of phosphodiester oligodeoxynucleotides in HL60 cells. Biochemistry. 32:1993;4855-4861.
13. 2+ and phospholipids. J Biol Chem. 261:1987;15424-15429.
14. Nakanishi H., Brewer K.A., Exton J.H. Activation of the ζ isozyme of protein kinase C by phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem. 268:1993;13-16.
15. Tonkinson J.L., Stein C.A. Patterns of intracellular compartmentalization, trafficking and acidification of 5′-fluorescein labeled phosphodiester and phosphorothioate oligodeoxynucleotides in HL60 cells. Nucleic Acids Res. 22:1994;4268-4275.
16. Schweigelshohn B., Presley J.F., Gorecki M., Vogel T., Carpentier Y.A., Maxfield F.R., Deckelbaum R.J. Effects of apoprotein E on intracellular metabolism of model triglyceride-rich particles are distinct from effects on cell particle uptake. J Biol Chem. 270:1995;1761-1769.
17. Martiny-Baron G., Kazanietz M.G., Mischak H., Blumberg P.M., Kochs G., Hug H., Marme D., Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem. 268:1993;9194-9197.
18. Bit R.R., Davis P.D., Elliott L.H., Harris W., Hill C.H., Keech E., Kumar H., Lawton G., Maw A., Nixon J.S., Vesey D., Wadsworth J., Wilkinson S. Inhibitors of protein kinase C. 3. Potent and highly selective bisindolylmaleimides by conformational restriction. J Med Chem. 36:1993;21-29.
19. II protein kinase C is required for proliferation . J Biol Chem. 268:1993;15847-15853.
20. Lozano J., Berra E., Municio M.M., Díaz-Meco M.T., Dominguez I., Sanz L., Moscat J. Protein kinase C ζ isoform is critical for κB-dependent promoter activation by sphingomyelinase. J Biol Chem. 269:1994;19200-19202.
21. Thelen M., Wymann M.P., Langen H. Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes. Proc Natl Acad Sci USA. 91:1994;4960-4964.
22. 2 activity in Swiss 3T3 cells. Wortmannin is not a specific inhibitor of phosphatidylinositol 3-kinase. J Biol Chem. 270:1995;25352-25355.
23. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 269:1994;5241-5248.
24. Ways D.K., Cook P.P., Webster C., Parker P.J. Effect of phorbol esters on protein kinase C-ζ J Biol Chem. 267:1992;4799-4805.
25. Berra E., Díaz-Meco M.T., Lozano J., Frutos S., Municio M.M., Sanchez P., Sanz L., Moscat J. Evidence of a role for MEK and MAPK during signal transduction by protein kinase C ζ EMBO J. 14:1995;6157-6163.
26. Ono Y., Fuji T., Ogita K., Kikkawa U., Igarashi K., Nishizuka Y. Protein kinase C ζ subspecies from rat brain Its structure, expression, and properties . Proc Natl Acad Sci USA. 86:1989;3099-3103.
27. Pelech S.L., Sanghera J.S. MAP kinases Charting the regulatory pathways . Science. 257:1992;1355-1356.
28. Nakanishi H., Exton J.H. Purification and characterization of the ζ isoform of protein kinase C from bovine kidney. J Biol Chem. 267:1992;16347-16354.
29. Folgueira L., McElhinny J.R., Bren G.D., MacMorran W.S., Díaz-Meco M.T., Moscat J., Paya C.V. Protein kinase C-ζ mediates NF-κB activation in human imunodeficiency virus-infected monocytes. J Virol. 70:1996;223-231.
30. Crespo P., Mischak H., Gutkind J.S. Overexpression of mammalian protein kinase C-ζ does not affect the growth characteristics of NIH 3T3 cells. Biochem Biophys Res Commun. 213:1995;266-272.
31. Ways D.K., Posekany K., deVente J., Garris T., Chen J., Hooker J., Qin W., Cook P., Fletcher D., Parker P. Overexpression of protein kinase C-ζ stimulates leukemic cell differentiation. Cell Growth Differ. 5:1994;1195-1203.
32. Gomez J., Martinez de Aragon A., Bonay P., Pitton C., Garcia A., Silva A., Fresno M., Alvarez F., Rebollo A. Physical association and functional relationship between protein kinase Cζ and the actin cytoskeleton. Eur J Immunol. 25:1995;2673-2678.
33. Mosthaf L., Kellerer M., Muhlhofer A., Mushack J., Seffer E., Haring H.U. Insulin leads to a parallel translocation of PI-3-kinase and protein kinase C ζ Exp Clin Endocrinol Diabetes. 104:1996;19-24.
34. Gomez J., Martinez C., Garcia A., Rebollo A. Association of phosphatidylinositol 3 kinase to protein kinase C ζ during interleukin-2 stimulation. Eur J Immunol. 26:1996;1781-1787.
35. Clague M.J., Thorpe C., Jones A.T. Phosphatidylinositol 3-kinase regulation of fluid phase endocytosis. FEBS Lett. 367:1995;272-274.
36. Li G., D'Souza-Schorey C., Barbieri M.A., Roberts R.L., Klippel A., Williams L.T., Stahl P. Evidence for phosphatidylinositol 3-kinase as a regulator of endocytosis via activation of Rab-5. Proc Natl Acad Sci USA. 92:1995;10207-10211.
37. Martys J.L., Wjasow C., Gangi D.M., Kielian M.C., McGraw T.E., Backer J.M. Wortmannin-sensitive trafficking pathways in Chinese hamster ovary cells. Differential effects on endocytosis and lysosomal sorting. J Biol Chem. 271:1996;10953-10962.
38. Joly M., Kazlauskas A., Corvera S. Phosphatidylinositol 3-kinase activity is required at a postendocytic step in platelet-derived growth factor receptor trafficking. J Biol Chem. 270:1995;13225-13230.
39. Joly M., Kazlauskas A., Fay F.S., Corvera S. Disruption of PDGF receptor trafficking by mutation of its PI-3 kinase binding sites. Science. 263:1994;684-686.
40. Rockwell P., O'Connor W.J., King K., Goldstein N.I., Zhang L.M., Stein C.A. Cell surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci USA. 94:1997;6523-6528.
41. Liu J.P. Protein kinase C and its substrates. Mol Cell Endocrinol. 116:1996;1-29.
42. Selbie L.A., Schmitz-Peiffer C., Sheng Y., Biden T.J. Molecular cloning and characterization of PKCτ, an atypical isoform of protein kinase C derived from insulin-secreting cells. J Biol Chem. 268:1993;24296-24302.
43. Carpentier Y., Van Gossu A., Dubois D.Y., Deckelbaum R.J. Lipid metabolism in parenteral nutrition. Rombeau J.L., Caldwell M.D. Clinical Nutrition Parenteral Nutrition . 1993;35-74 W. B. Saunders, Philadelphia.